KPV

KPV is a tripeptide fragment derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH), retaining alpha-MSH's anti-inflammatory activity without its pigmentation-related effects. It is studied for its interaction with melanocortin receptor pathways and its ability to inhibit NF-kB, a central transcription factor that drives inflammatory gene expression. By modulating this pathway, KPV is designed to help support the body's natural anti-inflammatory signaling, particularly in tissues such as the gut lining. EdgeRx offers KPV as a clinician-supervised recovery add-on, prescribed by licensed physicians for eligible patients seeking additional inflammatory pathway support alongside other recovery peptides.